# Precision Epigenomics

> Epigenomic liquid-biopsy diagnostics for cancer detection and monitoring.

## Why it is interesting

Tucson/UA-adjacent molecular diagnostics play — epigenomic signals in blood as a multi-cancer detection wedge versus mutation-only liquid biopsy approaches.

## Profile

- **Latest funding:** Not publicly disclosed
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** Not publicly disclosed
- **Stage:** seed
- **Status:** private
- **Industries:** biotech-life-sciences, healthtech
- **Coverage:** full
- **Last updated:** 2026-07-26

## Key facts

- Tucson epigenomic liquid-biopsy diagnostics
- Focus: cancer detection/monitoring from blood
- Website: precision-epigenomics.com

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** July 26, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/precision-epigenomics